arrow_back Back to App

Easier Access to Cancer Genetic Testing for Patients

This act aims to facilitate access to advanced genetic and laboratory tests for individuals diagnosed with cancer. It ensures coverage for these tests through Medicare, Medicaid, and CHIP programs, potentially reducing financial burdens on patients. Additionally, it establishes an educational program for physicians and the public on genomic testing.
Key points
Medicare will cover advanced genetic and laboratory tests for cancer patients, including DNA and RNA sequencing, without requiring a deductible.
Medicaid and CHIP (children's program) will also provide mandatory coverage for these tests, expanding access for lower-income individuals and children.
An educational program will be launched to increase awareness among physicians and the public about the importance and application of genomic testing in cancer diagnosis and treatment.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_755
Sponsor: Sen. Wicker, Roger F. [R-MS]
Process start date: 2025-02-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Finn Sawyer Access to Cancer Testing Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_755.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-02-26.

What are the main provisions?

Key points include:

  • Medicare will cover advanced genetic and laboratory tests for cancer patients, including DNA and RNA sequencing, without requiring a deductible.
  • Medicaid and CHIP (children's program) will also provide mandatory coverage for these tests, expanding access for lower-income individuals and children.
  • An educational program will be launched to increase awareness among physicians and the public about the importance and application of genomic testing in cancer diagnosis and treatment.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Wicker, Roger F. [R-MS].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health